SG Americas Securities
NMTC icon

SG Americas Securities’s NeuroOne Medical Technologies NMTC Stock Holding History

SG Americas Securities’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,409
Closed -$45K – 3323
2023
Q3 		$45K Sell
8,409
-560
-6% -$3.75K ﹤0.01% 2962
2023
Q2 		$65K Sell
8,969
-568
-6% -$4.6K ﹤0.01% 2121
2023
Q1 		$92K Buy
+9,537
New +$88.4K ﹤0.01% 2940

Other funds holding NMTC

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
WAAG
Wealth Alliance Advisory Group Wichita, Kansas $691M AUM 24.37% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

SG Americas Securities's NMTC Position: Q4 2023 in Review

SG Americas Securities sold out of NeuroOne Medical Technologies (NMTC) in Q4 2023, closing a stake of 8,409 shares — an estimated $45K sold.

SG Americas Securities first reported a position in NMTC in Q1 2023 and held it in 3 quarters. The position peaked at $92K in Q1 2023. 20 funds tracked by Wall St. Rank hold NMTC as of Q4 2023.

  • SG Americas Securities reported no remaining NeuroOne Medical Technologies position as of Q4 2023 after selling out during the quarter.
  • SG Americas Securities sold 8,409 NeuroOne Medical Technologies shares in Q4 2023, an estimated $45K.
  • SG Americas Securities first reported a position in NeuroOne Medical Technologies in Q1 2023 and held it in 3 quarters.
  • SG Americas Securities's NeuroOne Medical Technologies position peaked at $92K in Q1 2023.
  • 20 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q4 2023.

Based on SG Americas Securities's 13F filing for Q4 2023, filed 12 Jan 2024.